MEDIFAST INC (MED) Social Stream



MEDIFAST INC (MED): $49.99

1.47 (-2.86%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

A

Add MED to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

A

Ranked

#8 of 9

in industry

MEDIFAST INC (MED) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MED.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-23 2 $349 $345 $347 $68.74 404.8%
2022-05-03 2 $345 $341 $343 $68.74 398.98%
2022-06-02 2 $352 $345 $348.5 $68.74 406.98%
2022-08-05 1 $278 $278 $278 $68.74 304.42%
2022-11-07 1 $106 $106 $106 $68.74 54.2%
2023-02-22 1 $94 $94 $94 $68.74 36.75%
2023-05-03 1 $71 $71 $71 $68.74 3.29%
2023-06-22 1 $75 $75 $75 $68.74 9.11%
2023-08-01 1 $93 $93 $93 $68.74 35.29%
2023-08-08 1 $80 $80 $80 $68.74 16.38%
2023-10-13 2 $82 $80 $81 $68.74 17.84%
2023-11-07 2 $82 $67 $74.5 $68.74 8.38%
2023-12-01 2 $79 $67 $73 $68.74 6.2%

The Trend in the Analyst Price Target


Over the past 35 months, MED's average price target has gone down $163.

Over the past 40 weeks, MED's average upside potential has been -5.6%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-02 1 71 71 71.0 88.16 -19.46%
2023-05-03 1 71 71 71.0 85.20 -16.67%
2023-06-22 1 75 75 75.0 87.98 -14.75%
2023-11-07 2 82 67 74.5 68.89 8.14%
2023-12-01 2 79 67 73.0 68.31 6.87%

MED Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 43 months, MED's average broker recommendation rating worsened by 0.67.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, MEDIFAST INC's number of analysts covering the stock is higher than 19.81% of them.
  • MED has a lower variance in analysts' estimates than 8.56% of Consumer Cyclical stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, MEDIFAST INC's average analyst price target is greater than 1225.62% of them.
  • In the context of Food Products stocks, MEDIFAST INC's upside potential (average analyst target price relative to current price) is greater than 888.99% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Food Products industry with the ratings most similar to MEDIFAST INC are TR, BRBR, and SMPL.

What is the outlook for MED? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!